Insider filing · OLMA
Ian T Clark
Director
profile →
Ian T Clark sold $7.9M of Olema Pharmaceuticals (OLMA)
Executed Dec 19 2025, disclosed Dec 23 2025, 4 days later.
Value, as filed
$7.9M
264,800 sh across 3 lots
Executed
Dec 19 2025
the trade date, as filed
Disclosed
Dec 23 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ICIan T Clark (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Guardant Health, Inc. (GH). The largest single filing was $7.9M of OLMA (264,800 sh across 3 lots, as filed), executed Dec 19 2025.
The name
OLMA
Olema Pharmaceuticals, Inc.
OLMA · Healthcare · 17 filings in 24 months
ticker →
Healthcare · Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→